MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 161 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $90,047,000 | +46.5% | 5,983,161 | +13.8% | 0.02% | +30.8% |
Q3 2016 | $61,466,000 | +15.6% | 5,258,020 | +6.8% | 0.01% | +8.3% |
Q2 2016 | $53,168,000 | +22.1% | 4,922,956 | +4.5% | 0.01% | +20.0% |
Q1 2016 | $43,542,000 | -37.2% | 4,712,349 | +0.9% | 0.01% | -37.5% |
Q4 2015 | $69,341,000 | -9.4% | 4,672,572 | +0.2% | 0.02% | -20.0% |
Q3 2015 | $76,539,000 | -22.9% | 4,664,140 | +7.1% | 0.02% | -16.7% |
Q2 2015 | $99,317,000 | +82.6% | 4,354,092 | +21.7% | 0.02% | +84.6% |
Q1 2015 | $54,382,000 | +38.2% | 3,577,737 | +9.5% | 0.01% | +30.0% |
Q4 2014 | $39,336,000 | +15.8% | 3,267,128 | +9.0% | 0.01% | 0.0% |
Q3 2014 | $33,975,000 | -6.6% | 2,996,062 | -0.5% | 0.01% | 0.0% |
Q2 2014 | $36,392,000 | -2.0% | 3,012,595 | -5.5% | 0.01% | -9.1% |
Q1 2014 | $37,152,000 | -32.8% | 3,189,012 | +2.0% | 0.01% | -35.3% |
Q4 2013 | $55,259,000 | +26.5% | 3,125,535 | +2.9% | 0.02% | +13.3% |
Q3 2013 | $43,691,000 | +8.5% | 3,036,222 | +13.6% | 0.02% | 0.0% |
Q2 2013 | $40,265,000 | – | 2,673,622 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |